The incidence of brain metastases (BM) in breast cancer patients has increased over the last
decade, presumably due to advances in systemic treatment. Today, breast cancer is the …

The overexpression or amplification of the human epidermal growth factor receptor 2 gene
(HER2/neu) is associated with high risk of brain metastasis (BM). The identification of …

Treatment options as well as the characteristics for therapeutic decisions in patients with
primary and advanced breast cancer are increasing in number and variety. New targeted …

Background There are no clinically useful biomarkers predictive of brain metastases (BM) in
breast cancer. In this study, we investigated the correlation between expression of selected …

Primary malignancies of the lung, skin (melanoma), and breast have higher propensity for
metastatic spread to the brain. Advances in molecular tumour profiling have aided the …

The authors discuss various studies concerning the development of a novel therapeutic
agent for improved prognosis of brain metastases (BCBMs) in women with breast cancer …

Breast cancer is the second most common cause of central nervous system (CNS)
metastases and the most common cause of leptomeningeal metastases. The brain, cranial …

El congreso más importante a nivel mundial sobre cáncer es el de la American Society of
Clinical Oncology, que tiene carácter anual y en el que se presentan las novedades más …